Results 181 to 190 of about 45,688 (235)

Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777. [PDF]

Int J Mol Sci
Nishikubo H, Ma D, Sano T, Imanishi D, Sakuma T, Fan C, Yamamoto Y, Yamamori M, Yashiro M.   +8 more
europepmc   +1 more source

FGFR2 Gene Alteration Positive [PDF]

, 2020
openaire   +1 more source

GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation. [PDF]

Cancers (Basel)
Tanikella P, Nenad W, Courtine C, Dai Y, Deng Q, Zou B, Osazuwa-Peters N, Schrank TP, Wu D.   +8 more
europepmc   +1 more source

GALNT3 is a novel target driving lymphomagenesis via O-glycosylation of FGFR2. [PDF]

Cell Commun Signal
Sun R, Wang W, Gao Y, Aximujiang K, Li Y, Innocent A, Xu Z, Ma J.   +7 more
europepmc   +1 more source

FGFR2 Gene Fusion Positive [PDF]

, 2020
openaire   +1 more source

Prenatally Diagnosed Beare-Stevenson Cutis Gyrata Syndrome With a Novel FGFR2 Variant. [PDF]

Prenat Diagn
Crane HM, Giardine R, Strong A, Wild KT, Zackai E, Dugoff L, Sparks TN, Coleman B, Moldenhauer JS.   +8 more
europepmc   +1 more source

Role of lipid rafts in the FGFR2c-mediated oncogenic signaling by involvement of TRPA1 channel in pancreatic ductal adenocarcinoma cells. [PDF]

Cell Death Dis
Mancini V, Manganelli V, Garofalo T, Sorice M, Raffa S, Scullari D, Ranieri D, Belleudi F.   +7 more
europepmc   +1 more source

Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy. [PDF]

J Liver Cancer
Hong JY, Sinn DH, Ha SY.
europepmc   +1 more source

Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma. [PDF]

PLoS One
Narisawa T, Naito S, Mitsuda Y, Ohe R, Sato H, Kobayashi C, Miyano Y, Ito H, Futakuchi M, Tsuchiya N.   +9 more
europepmc   +1 more source

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? [PDF]

J Gastrointest Cancer
Barsch M, Dopfer EP, Schultheis AM, Quante M.   +3 more
europepmc   +1 more source